A. C. Eschenbach

发表

A. C. Eschenbach, 1981, Current problems in cancer.

Sexual rehabilitation in a cancer center: Diagnosis and outcome in 384 consultations

L. Schover, A. C. Eschenbach, R. Evans, 1987, Archives of sexual behavior.

Erratum: "American cancer society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancer" (CA A Cancer Journal for Clinicians) (2001) vol. 51 (38-75))

Tim Byers, David A. Rothenberger, T. Byers, 2001 .

Systemic therapy for genitourinary cancers

C. Logothetis, Douglas E. Johnson, A. C. Eschenbach, 1989 .

A comparison of biochemical outcome following salvage prostatectomy or cryosurgery for locally recurrent prostate cancer after radiation therapy

B. Leibovich, M. Blute, H. Zincke, 2001 .

Amplification of the Y chromosome in three murine tumor cell lines transformed in vivo by different human prostate cancers

A. Multani, S. Pathak, M. Ozen, 1999, In Vitro Cellular & Developmental Biology - Animal.

The Management of Stage C Adenocarcinoma of the Prostate with External Beam Radiation Therapy

G. Zagars, Douglas E. Johnson, A. C. Eschenbach, 1987 .

Doxorubin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: A preliminary report

C. Logothetis, M. Samuels, A. C. Eschenbach, 1982 .

DMF regimen for hormone-refractory adenocarcinoma of the prostate. The first 42 patients

C. Logothetis, M. Samuels, A. C. Eschenbach, 1982 .

Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer

H. Grossman, B. Czerniak, D. Johnston, 1999, Oncogene.

Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia

B. Czerniak, D. Johnston, C. Logothetis, 1997, Oncogene.

ALSO: Update 2001—Testing for Early Lung Cancer Detection Cancers: of Early Detection Guidelines for Prostate, Colorectal, and Endometrial American Cancer Society Guidelines for the Early Detection of Cancer: Update

B. Levin, D. Saslow, Robert A. Smith, 2005 .

Human tumor-infiltrating lymphocytes

C. Balch, K. Itoh, K. Hayakawa, 1993 .

Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial

George Starkschall, John A. Antolak, Isaac I. Rosen, 2003 .

Proteinsof HumanUrine . II . Identificationby Two-Dimensional Electrophoresisof a New CandidateMarker for ProstaticCancer Tollaksen

J. J. Edwards, N. Anderson, A. C. Eschenbach, 2004 .

Sexual Function and Female Radical Cystectomy: A Case Series

A. C. Eschenbach, Leslie R. Schove, 1985 .

Conservative management of the retroperitoneum for stages I and II nonseminomatous germ cell tumors

M. Gleave, D. Swanson, A. C. Eschenbach, 1992, World Journal of Urology.

Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation

A. Pollack, G. Zagars, A. C. Eschenbach, 1997, Cancer.

Corrigendum: Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells (Cancer Letters (1995) 93 (147-155))

M. Campbell, T. McDonnell, M. Marin, 1996 .

The Clinical Problem of Prostate Cancer

C. Wood, A. C. Eschenbach, 2000 .

Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.

M. Gleave, L. Chung, A. V. von Eschenbach, 1991, Cancer research.

Identification of p53 gene mutations in bladder cancers and urine samples.

P. Green, B. Vogelstein, F. Marshall, 1991, Science.

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.

T. Hsu, L. Chung, M. Freeman, 1990, Proceedings of the National Academy of Sciences of the United States of America.

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

W. W. Nichols, P. Troncoso, A. V. von Eschenbach, 1993, Journal of the National Cancer Institute.

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.

P. Troncoso, C. Logothetis, A. V. von Eschenbach, 1999, The Journal of urology.

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

D. Johnston, P. Troncoso, C. Logothetis, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

L. Chung, A. V. von Eschenbach, S. Pathak, 1994, Cancer research.

Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.

I. Fidler, A. V. von Eschenbach, S. Naito, 1986, Cancer research.

Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

C. Balch, A. V. von Eschenbach, L. Riley, 1990, Archives of surgery.

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

George Starkschall, K., Alan Pollack, 2002, International journal of radiation oncology, biology, physics.

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

T. McDonnell, P. Troncoso, C. Logothetis, 1997, The Journal of urology.

Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.

A. V. von Eschenbach, A. Pollack, G. Zagars, 1995, International journal of radiation oncology, biology, physics.

Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis.

M. Gleave, L. Chung, A. V. von Eschenbach, 1992, The Journal of urology.

Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.

M. Gleave, L. Chung, A. V. von Eschenbach, 1992, Cancer research.

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.

A Pollack, A. V. von Eschenbach, A. Pollack, 1995, International journal of radiation oncology, biology, physics.

Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study.

A. V. von Eschenbach, D. Hussey, G. Zagars, 1988, International journal of radiation oncology, biology, physics.

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.

C. Dinney, A. V. von Eschenbach, A. Pollack, 1995, International journal of radiation oncology, biology, physics.

The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate.

A. V. von Eschenbach, G. Zagars, D. Johnson, 1988, International journal of radiation oncology, biology, physics.

Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo.

T. McDonnell, M. Sarkiss, A. V. von Eschenbach, 1998, International journal of molecular medicine.

Therapy and prognosis for male anterior urethral carcinoma: an update.

C. Dinney, R. Babaian, A. V. von Eschenbach, 1994, Urology.

Lack of prostate cancer radiosensitization by androgen deprivation.

A. V. von Eschenbach, F. Ashoori, A. Pollack, 2001, International journal of radiation oncology, biology, physics.

Sexual and marital relationships after treatment for nonseminomatous testicular cancer.

L. Schover, A. V. von Eschenbach, A. C. Eschenbach, 1985, Urology.

Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer.

A. V. von Eschenbach, A. Pollack, G. Zagars, 2001, Urology.

Spermatic cord sarcoma: outcome, patterns of failure and management.

M. Ballo, B. Feig, P. Pisters, 2001, The Journal of urology.

Different growth pattern and biologic behavior of human renal cell carcinoma implanted into different organs of nude mice.

I. Fidler, A. V. von Eschenbach, S. Naito, 1987, Journal of the National Cancer Institute.

Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

C. Bucana, I. Fidler, A. V. von Eschenbach, 1997, The American journal of pathology.

Sexual and marital relationships after radiotherapy for seminoma.

L. Schover, A. V. von Eschenbach, A. C. Eschenbach, 1986, Urology.

Sexual dysfunction following therapy for cancer of the prostate, testis, and penis.

A. C. Eschenbach, 1980 .

Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens.

D. Grignon, P. Troncoso, R. Babaian, 1989, Urology.

Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome.

B. Têtu, C. Logothetis, A. V. von Eschenbach, 1989, Urology.

Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+.

T. McDonnell, A. V. von Eschenbach, D. McConkey, 1996, Oncogene.

The biologic dilemma of early carcinoma of the prostate

A. C. Eschenbach, 1996 .

Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.

S. H. Lin, A. V. von Eschenbach, W. Zhang, 1995, Cancer research.

Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.

M. Gleave, L. Chung, J. Hsieh, 1993, Cancer research.

Role of intravesical mitomycin C in management of superficial bladder tumors.

A. V. von Eschenbach, S. Crooke, D. Johnson, 1980, Urology.

Original Articles: Bladder Cancer: Management of Transitional Cell Carcinoma Involving Von Brunn's Nests

C. Dinney, R. Babaian, A. V. von Eschenbach, 1995 .

Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.

C. Logothetis, A. V. von Eschenbach, D. Johnson, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.

P. Troncoso, L. Chung, A. V. von Eschenbach, 1994, Urology.

The Heterogeneity of Prostate Cancer: Implications for Research

A. C. Eschenbach, 1989 .

Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance.

R. Babaian, A. V. von Eschenbach, C. Dunphy, 1989, Urology.

Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomy.

A. K. Levinson, D. Grignon, R. Babaian, 1992, Urology.